Market Closed -
Nasdaq
04:00:03 2024-05-31 pm EDT
|
5-day change
|
1st Jan Change
|
0.7971
USD
|
+11.95%
|
|
+12.06%
|
-61.68%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
76.61
|
150.8
|
113.6
|
58.88
|
91.77
|
43.53
|
-
|
-
|
Enterprise Value (EV)
1 |
76.61
|
150.8
|
113.6
|
58.88
|
91.77
|
43.53
|
43.53
|
43.53
|
P/E ratio
|
-3.05
x
|
-6.45
x
|
-8.16
x
|
-1.96
x
|
-3.15
x
|
-1.19
x
|
-0.9
x
|
-1.58
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
-
|
75.4
x
|
8.12
x
|
-
|
24,215
x
|
12.3
x
|
3.75
x
|
1.24
x
|
EV / Revenue
|
-
|
75.4
x
|
8.12
x
|
-
|
24,215
x
|
12.3
x
|
3.75
x
|
1.24
x
|
EV / EBITDA
|
-3.6
x
|
-
|
-8.96
x
|
-
|
-
|
-0.67
x
|
-0.63
x
|
-
|
EV / FCF
|
-
|
-22.7
x
|
-
|
-2.27
x
|
-
|
-1.22
x
|
-1.17
x
|
-2.24
x
|
FCF Yield
|
-
|
-4.41%
|
-
|
-44.1%
|
-
|
-81.7%
|
-85.4%
|
-44.7%
|
Price to Book
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Nbr of stocks (in thousands)
|
17,101
|
24,884
|
28,407
|
36,121
|
44,122
|
53,871
|
-
|
-
|
Reference price
2 |
4.480
|
6.060
|
4.000
|
1.630
|
2.080
|
0.8080
|
0.8080
|
0.8080
|
Announcement Date
|
3/25/20
|
3/25/21
|
3/28/22
|
3/30/23
|
3/18/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
-
|
2
|
14
|
-
|
0.00379
|
3.541
|
11.6
|
35.08
|
EBITDA
1 |
-21.29
|
-
|
-12.68
|
-
|
-
|
-64.58
|
-68.67
|
-
|
EBIT
1 |
-21.31
|
-19.79
|
-12.9
|
-26.91
|
-25.41
|
-29.47
|
-41.31
|
-23.02
|
Operating Margin
|
-
|
-989.46%
|
-92.17%
|
-
|
-670,354.88%
|
-832.15%
|
-356.07%
|
-65.63%
|
Earnings before Tax (EBT)
1 |
-21.16
|
-19.77
|
-12.78
|
-28.01
|
-27.26
|
-31.84
|
-42.6
|
-24.34
|
Net income
1 |
-21.16
|
-19.77
|
-12.78
|
-28.01
|
-27.26
|
-31.84
|
-42.3
|
-24.34
|
Net margin
|
-
|
-988.49%
|
-91.27%
|
-
|
-719,290.24%
|
-899.12%
|
-364.62%
|
-69.4%
|
EPS
2 |
-1.470
|
-0.9400
|
-0.4900
|
-0.8300
|
-0.6600
|
-0.6800
|
-0.8950
|
-0.5100
|
Free Cash Flow
1 |
-
|
-6.646
|
-
|
-25.98
|
-
|
-35.55
|
-37.17
|
-19.47
|
FCF margin
|
-
|
-332.28%
|
-
|
-
|
-
|
-1,003.85%
|
-320.39%
|
-55.52%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
3/25/20
|
3/25/21
|
3/28/22
|
3/30/23
|
3/18/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Net sales
1 |
10
|
-
|
-
|
-
|
-
|
-
|
-
|
0.0012
|
0.00259
|
0.00499
|
0.7618
|
1.097
|
1.679
|
1.55
|
1.844
|
EBITDA
|
3.187
|
-6.203
|
-6.014
|
-6.218
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
3.113
|
-7.188
|
-7.121
|
-7.23
|
-5.372
|
-5.459
|
-5.961
|
-6.52
|
-7.467
|
-8.267
|
-6.642
|
-6.712
|
-6.702
|
-6.65
|
-6.496
|
Operating Margin
|
31.13%
|
-
|
-
|
-
|
-
|
-
|
-
|
-543,349.17%
|
-288,283.78%
|
-165,667.74%
|
-871.94%
|
-612.02%
|
-399.15%
|
-429.03%
|
-352.28%
|
Earnings before Tax (EBT)
1 |
2.983
|
-7.34
|
-7.239
|
-7.309
|
-6.123
|
-5.739
|
-6.216
|
-7.339
|
-7.967
|
-10.92
|
-6.928
|
-7
|
-6.991
|
-6.6
|
-6.446
|
Net income
1 |
2.983
|
-7.34
|
-7.239
|
-7.309
|
-6.123
|
-5.739
|
-6.216
|
-7.339
|
-7.967
|
-10.92
|
-6.928
|
-7
|
-6.991
|
-6.6
|
-6.446
|
Net margin
|
29.83%
|
-
|
-
|
-
|
-
|
-
|
-
|
-611,560.83%
|
-307,611.58%
|
-218,879.76%
|
-909.53%
|
-638.28%
|
-416.38%
|
-425.81%
|
-349.57%
|
EPS
2 |
0.1000
|
-0.2400
|
-0.2200
|
-0.2100
|
-0.1700
|
-0.1500
|
-0.1600
|
-0.1800
|
-0.1600
|
-0.2300
|
-0.1500
|
-0.1500
|
-0.1500
|
-0.1400
|
-0.1300
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
3/28/22
|
5/12/22
|
8/10/22
|
11/10/22
|
3/30/23
|
5/12/23
|
8/10/23
|
11/13/23
|
3/18/24
|
5/15/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-
|
-6.65
|
-
|
-26
|
-
|
-35.5
|
-37.2
|
-19.5
|
ROE (net income / shareholders' equity)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Assets
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Cash Flow per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
1 |
-
|
0.26
|
-
|
0.87
|
-
|
4
|
4
|
4
|
Capex / Sales
|
-
|
13.06%
|
-
|
-
|
-
|
112.95%
|
34.48%
|
11.4%
|
Announcement Date
|
3/25/20
|
3/25/21
|
3/28/22
|
3/30/23
|
3/18/24
|
-
|
-
|
-
|
Last Close Price
0.808
USD Average target price
9
USD Spread / Average Target +1,013.86% Consensus |
1st Jan change
|
Capi.
|
---|
| -61.68% | 42.94M | | +40.73% | 739B | | +32.83% | 598B | | -6.30% | 353B | | +15.15% | 318B | | +4.05% | 285B | | +15.00% | 240B | | -5.52% | 206B | | +6.17% | 164B | | -0.45% | 162B |
Other Pharmaceuticals
|